Conservative management of malignant and borderline ovarian tumor;Chirurgie conservatrice des tumeurs malignes et borderline de l'ovaire

Bulletin du Cancer

Volumn 89, Issue 12, 2002, Pages 1019-1026

  Morice, Philippe ^a   Camatte, Sophie ^a   Wickart Poque, Fabienne ^a   Rouzier, Roman ^a   Pautier, Patricia ^a   Pomel, Christophe ^a   Lhommé, Catherine ^a   Haie Meder, Christine ^a   Duvillard, Pierre ^a   Castaigne, Damienne ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Borderline tumor; Conservative surgery; Ovarian cancer; Pregnancy; Recurrence

Indexed keywords

CANCER RECURRENCE; CANCER STAGING; CONSERVATIVE TREATMENT; CURETTAGE; DISEASE SEVERITY; EPITHELIUM TUMOR; FERTILITY; FOLLOW UP; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NON-EPITHELIAL TUMORS; OVARIECTOMY; OVARY TUMOR; PELVIS LYMPHADENECTOMY; PERITONEAL BIOPSY; PERITONEUM; REVIEW;

AGE FACTORS; FEMALE; FERTILITY; GERMINOMA; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS;

EID: 0036962365     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Slayton RE, Park RC, Silverberg SG, Shingleton H, Creasman WT, Blessing JA. Vincristine, actinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary: a Gynecologic Oncology Group Study (a final report). Cancer 1985; 56: 243-8.
2. Krepart G, Smith JP, Rutledge F, Delclos L. The treatment for dysgerminoma of the ovary. Cancer 1978; 41: 986-90.
3. Schwartz PE. Combination chemotherapy in the management of ovarian germ cell malignancies. Obstet Gynecol 1984; 64: 564-72.
4. Gershenson DM, Del Junco G, Herson J, Rutledge FN. Endodermal sinus tumor of the ovary: the MD Anderson experience. Obstet Gynecol 1983; 61: 194-202.
5. Creasman WT, Fetter BF, Hammond CB, Parket RT. Germ cell malignancies of the ovary. Obstet Gynecol 1979; 53: 226-30.
6. Brewer M, Gershenson DM, Herzog CE, Mitchell MF, Silva EG, Wharton JT. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol 1999; 17: 2670-5.
7. Zanetta G, Bonazzi C, Cantu M, Binidagger S, Locatelli A, Bratina G, et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol 2001; 19: 1015-20.
8. Low JJ, Perrin LC, Crandon AJ, Hacker NF. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors: a review of 74 cases. Cancer 2000; 89: 391-8.
9. Gershenson DM. Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol 1988; 6: 270-5.
10. Duvillard P. Tumeurs ovariennes à la limite de la malignité. Ann Pathol 1996; 16: 396-405.
11. Julian C, Woodruff D. The biologic behavior of low-grade papillary serous carcinoma of the ovary. Obstet Gynecol 1972; 40: 860-7.
12. Hart WR, Norris HJ. Bordeline and malignant mucinous tumors of the ovary. Cancer 1973; 31: 1031-44.
13. Tazelaar H, Bostwick D, Ballon S. Conservative treatment of borderline ovarian tumors. Obstet Gynecol 1985; 66: 417-21.
14. Tasker M, Langley FA. The outlook for women with borderline epithelial tumours of the ovary. Br J Obstet Gynaecol 1985; 92: 969-73.
15. Bostwick D, Tazelaar H, Ballon S, Hendriskson MR, Kempson RL. Ovarian epithelial tumors of borderline malignancy: a clinical and pathologic study of 109 cases. Cancer 1986; 58: 2052-65.
16. Lim-Tan S, Cajigas H, Scully R. Ovarian cystectomy for serous borderline. Tumors: a follow-up study of 35 cases. Obstet Gynecol 1988; 72: 775-80.
17. Rice L, Berkowitz R, Mark S, Yavner D, Lage J. Epithelial ovarian tumors of borderline malignancy. Gynecol Oncol 1990; 39: 195-8.
18. Massad S, Hunter V, Szpak C, Clarke-Pearson D, Creasman W. Epithelial ovarian tumors of low malignant potential. Obstet Gynecol 1991; 78: 1027-32.
19. Leake J, Currie J, Rosenshein N, Woodruff D. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol 1992; 47: 150-8.
20. Manchul LA, Simm J, Levin W, Fyles AW, Dembo AJ, Pringle JF, et al. Borderline epithelial ovarian tumours: a review of 81 cases with an assessment of the impact of the treatment. Int J Rad Oncol Biol Phys 1992; 22: 867-74.
21. Piura B, Dganis R, Blicksteins I, Yanai-Inbar I, Czernobilsky B, Glezerman M. Epithelial ovarian tumors of borderline malignancy: a study of 50 cases. Int J Gynecol Cancer 1992; 2: 189-97.
22. Barnhill D, Kurman R, Brady M, Omura GA, Yordan E, Given FT, et al. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecoloic Oncology Group study. J Clin Oncol 1995; 13: 2752-6.
23. Kennedy AW, Hart WR. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors): a long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer 1996; 78: 278-86.
24. Tamakoshi K, Kikkawa F, Nakashima N, Tamakoshi A, Kawai M, Furuhashi Y, et al. Clinical behaviour of borderline ovarian tumors: a study of 150 cases. J Surg Oncol 1997; 64: 147-52.
25. Darai E, Teboul J, Fauconnier A, Scoazec JY, Benifla JL, Madelenat P. Management and outcome of borderline ovarian tumors indicentally discovered at or after laparoscopy. Acta Obstet Gynecol Scand 1998; 77: 451-7.
26. Gotlieb W, Flikker S, Davidson B, Korach Y, Kopolovic J, Ben-Baruch G. Borderline tumors of the ovary: fertiliy treatment, conservative management, and pregnancy outcome. Cancer 1998; 82: 141-6.
27. Morris RT, Gershenson DM, Silvia EG, Follen M, Morris M, Wharton JT. Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol 2000; 95: 541-7.
28. Camatte S, Rouzier R, Boccara-Dekeyser J, Pautier P, Pomel C, Lhomme C, et al. Pronostic et fertilité après traitement conservateur d'une tumeur ovarienne à la limite de la malignité: revue d'une série continue de 68 cas. Gynecol Obstet Fertil 2002; 30: 583-91.
29. Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. Behavior of borderlin tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 2001; 19: 2656-64.
30. Seracchioli R, Venturoli S, Colombo FM, Govoni F, Missiroli S, Bagnoli A. Fertility and tumor recurrence rate after conservative laparoscopic management of young women with early-stage borderline ovarian tumors. Fertil Steril 2001; 76: 999-1004.
31. Morice P, Camatte S, El Hassan J, Lhommé C, Duvillard P, Castaigne D. Clinical outcomes and fertility results after conservative treatment for ovarian borderline tumor. Fertil Steril 2001; 75: 92-6.
32. Camatte S, Morice P, Pautier P, Lhommé C, Duvillard P, Castaigne D. Fertility results after conservative treatment of advanced stage serous borderline tumors of the ovary. Br J Obstet Gynaecol 2002; 109: 376-80.
33. Beiner ME, Gotlieb WH, Davidson B, Kopolovic J, Ben-Baruch G. Infertility treatment after conservative management of borderline ovarian tumors. Cancer 2001; 92: 320-5.
34. Miller DM, Ehlen TG, Saleh EA. Successful term pregnancy following conservative debulking surgery for a stage IIIA serous low-malignant-potential tumor of the ovary: a case report. Gynecol Oncol 1997; 66: 535-8.
35. Morice P, Camatte S, Rey A, Lhommé C, Haie-Meder C, Duvillard P, et al. Prognostic factors of patients with advanced stage serous borderline tumor of the ovary (submitted for publication).
36. Gershenson D, Silva E, Levy L, Burke TW, Wolf JK, Tornos C. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 1998; 82: 1096-103.
37. Nijman HW, Burger CW, Baak JP, Schats R, Vermorken JB, Kenemans P. Borderline malignancy of the ovary and controlled hyperstimulation: a report of 2 cases. Eur J Cancer 1992; 28A: 1971-2.
38. Mantzavinos T, Kanakas N, Genatas C, Papadias K, Zourlas PA. Five years' follow-up in two patients with borderline tumours of the ovary hyperstimulated by gonadotrophin therapy for in-vitro fertilization. Human Reprod 1994; 9: 2032-3.
39. Hershkovitz R, Lunenfeld E, Piura B, Pak I, Leiberman JR, Yanai-Inbar I, et al. Ovulation induction in three infertile patients with ovarian borderline tumor. Isr J Obstet Gynecol 1998; 9: 271-5.
40. Hoffman JS, Laird L, Benadiva C, Dreiss R. In vitro fertilization following conservative management of stage 3 serous borderline tumor of the ovary. Gynecol Oncol 1999; 74: 515-8.
41. e Congrès de la Société française d'oncologie gynécologique. Poitiers, France, 5-6 novembre 1999.
42. Lawal AH, Lynch CB. Borderline ovarian cancer, bilateral surgical castration, chemotherapy and a normal delivery after ovum donation and in vitro fertilisation-embryo transfer. Br J Obstet Gynaecol 1996; 103: 931-2.
43. Brown C, Hyman J, Almadrones L, Curtin J, Hoskins W. Conservative surgical management of early epithelial ovarian cancer (EOC). Proc ASCO 1995; 14: 766.
44. Colombo N, Chiari S, Maggioni A, Bocciolone L, Torri V, Mangioni C. Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol Oncol 1994; 55: S47-51.
45. Zanetta G, Chiari S, Rota S, Bratina G, Maneo A, Torri V, et al. Conservative surgery for stage I ovarian carcinoma in women of child-bearing age. Br J Obstet Gynaecol 1997; 104: 1030-5.
46. Morice P, Wicart-Poque F, Rey A, Lhommé C, El-Hassan J, Duvillard P, et al. Conservative treatment of epithelial ovarian cancer. Cancer 2001; 92: 2412-8.
47. Morice P, Wicart-Poque F, Rey A, Camatte S, Rouzier R, Pautier P, et al. Résultats carcinologiques et fertilité après traitement conservateur des cancers épithéliaux de l'ovaire. Gynecol Obstet Fertil 2002; 30: 684-91.
48. DiSaia PJ. Conservative management of the patient with early gynecologic cancer. CA Cancer J Clin 1989; 39: 135-54.
49. Raspagliesi F, Fontanelli R, Paladini D, Di Re EM. Conservative surgery in high-risk epithelial ovarian carcinoma. J Am Coll Surg 1997; 185: 457-60.
50. Vergote I, De Brabanter J, Fyles A, Bertelsen K, Einhorn N, Sevelda P, et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001; 357: 176-82.
51. Benedetti-Panici P, Greggi S, Maneschi F, Scambia G, Amoroso M, Rabitti C, et al. Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol 1993; 51: 150-4.
52. Walter AJ, Magrina JF. Contralateral pelvic and aortic lymph node metastasis in clinical stage I epithelial ovarian cancer. Gynecol Oncol 1999; 74: 128-9.
53. Cass I, Li AJ, Runowicz CD, Fields AL, Goldberg GL, Leuchter RS, et al. Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas. Gynecol Oncol 2001; 80: 56-61.
54. Munnell EW. Is conservative therapy ever justified in stage I (IA) cancer of the ovary? Am J Obstet Gynecol 1969; 103: 641-50.
55. Benjamin I, Morgan MA, Rubin SC. Occult bilateral involvement in stage I epithelial ovarian cancer. Gynecol Oncol 1999; 72: 288-91.
56. Moore MM, Tewari K, Rose GS, Fruehauf JP, DiSaia PJ. Long-term consequences following conservative management of epithelial ovarian cancer in an infertile patient. Gynecol Oncol 1999; 73: 452-4.